Transparency in practice: Evidence from 'verification analyses' issued by the Polish Agency for Health Technology Assessment in 2012-2015.

about

Transparency in practice: Evidence from 'verification analyses' issued by the Polish Agency for Health Technology Assessment in 2012-2015.

Item

http://www.wikidata.org/entity/Q47178833

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Transparency in practice: Evid ...... ology Assessment in 2012-2015.

@en

Transparency in practice: Evid ...... ology Assessment in 2012-2015.

@nl

type

Item

label

Transparency in practice: Evid ...... ology Assessment in 2012-2015.

@en

Transparency in practice: Evid ...... ology Assessment in 2012-2015.

@nl

prefLabel

Transparency in practice: Evid ...... ology Assessment in 2012-2015.

@en

Transparency in practice: Evid ...... ology Assessment in 2012-2015.

@nl

P1476

Transparency in practice: Evid ...... ology Assessment in 2012-2015.

@en

P2093

Lawrence King

http://www.w3.org/2001/XMLSchema#string

Marcell Csanádi

http://www.w3.org/2001/XMLSchema#string

Natalia Nicholls

http://www.w3.org/2001/XMLSchema#string

Olga Löblová

http://www.w3.org/2001/XMLSchema#string

Piotr Ozierański

http://www.w3.org/2001/XMLSchema#string

P2860

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries

Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology

Toward transparency in health technology assessment: a checklist for HTA reports.

A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in Poland.

Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland?

The National Institute for Health and Clinical Excellence Single Technology Appraisal process: lessons from the first 4 years.

From idealistic rookies to a regional leader: the history of health technology assessment in Poland.

Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe.

Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012-2014, a retrospective analysis.

P304

1-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1744133117000342

http://www.w3.org/2001/XMLSchema#string

P50

Martin McKee

Zoltan Kalo

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29307327

http://www.w3.org/2001/XMLSchema#string